Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus
- PMID: 20484303
- DOI: 10.1093/ndt/gfq265
Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus
Abstract
Pulmonary alveolar proteinosis (PAP) has been associated with the immunosuppressant sirolimus in transplant patients. PAP is a progressive lung disease characterized by the accumulation of surfactant-like material in the lungs leading to decreased pulmonary function with shortness of breath and cough as common symptoms. We report a rare case of sirolimus-associated PAP in a kidney transplant recipient with a history of end-stage renal disease secondary to haemolytic uraemic syndrome (HUS) and review of the literature. Discontinuation of sirolimus and initiation of tacrolimus led to resolution of PAP without recurrence of HUS.
Similar articles
-
An unusual presentation of sirolimus associated cough in a renal transplant recipient.Transplant Proc. 2007 Dec;39(10):3463-4. doi: 10.1016/j.transproceed.2007.09.033. Transplant Proc. 2007. PMID: 18089408
-
Chylous ascites in a renal transplant recipient under sirolimus (rapamycin) treatment.Transplant Proc. 2008 Jun;40(5):1756-8. doi: 10.1016/j.transproceed.2008.02.074. Transplant Proc. 2008. PMID: 18589188
-
Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.Nephrol Dial Transplant. 2005 Nov;20(11):2517-23. doi: 10.1093/ndt/gfh957. Epub 2005 Jun 28. Nephrol Dial Transplant. 2005. PMID: 15985508
-
Tacrolimus-associated hemolytic uremic syndrome: a case analysis.J Nephrol. 2003 Jul-Aug;16(4):580-5. J Nephrol. 2003. PMID: 14696762 Review.
-
Considerations in sirolimus use in the early and late post-transplant periods.Expert Opin Drug Saf. 2009 Jul;8(4):421-34. doi: 10.1517/14740330903037156. Expert Opin Drug Saf. 2009. PMID: 19522662 Review.
Cited by
-
Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient.Lung India. 2020 May-Jun;37(3):252-256. doi: 10.4103/lungindia.lungindia_484_19. Lung India. 2020. PMID: 32367848 Free PMC article.
-
Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature.J Transplant. 2014;2014:305931. doi: 10.1155/2014/305931. Epub 2014 Dec 18. J Transplant. 2014. PMID: 25580277 Free PMC article. Review.
-
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.Diagn Pathol. 2012 Mar 14;7:25. doi: 10.1186/1746-1596-7-25. Diagn Pathol. 2012. PMID: 22416975 Free PMC article.
-
Beyond "Big Eaters": The Versatile Role of Alveolar Macrophages in Health and Disease.Int J Mol Sci. 2021 Mar 24;22(7):3308. doi: 10.3390/ijms22073308. Int J Mol Sci. 2021. PMID: 33804918 Free PMC article. Review.
-
Lung Transplant Recipient with Pulmonary Alveolar Proteinosis.Case Rep Transplant. 2016;2016:4628354. doi: 10.1155/2016/4628354. Epub 2016 Apr 24. Case Rep Transplant. 2016. PMID: 27213073 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials